A Study of RGX-202-01 as a Single Agent and as Combination Therapy in Patients With Advanced Gastrointestinal Malignancies
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Colorectal Cancer
- Colorectal Carcinoma
- Colorectal Neoplasms
- Gastric Cancer
- Gastric Neoplasm
- Gastrointestinal Cancer
- Gastrointestinal Neoplasms
- Pancreatic Cancer
- Pancreatic Neoplasm
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: Non-RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03597581
- Collaborators
- Not Provided
- Investigators
- Not Provided